Patents by Inventor John S. Marken

John S. Marken has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of screening for antagonists and agonists of polypeptides having kinase functions
    Patent number: 6867013
    Abstract: The invention is directed to purified and isolated human polypeptides having kinase function, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, the use of such polypeptides and fragmented peptides in phosphorylation reactions and as molecular weight markers, the use of such polypeptides and fragmented peptides as controls for peptide fragmentation, the use of such polypeptides in screening assays, and kits comprising these reagents.
    Type: Grant
    Filed: December 18, 2001
    Date of Patent: March 15, 2005
    Assignee: Immunex Corporation
    Inventors: G. Duke Virca, Timothy A. Bird, Dirk M. Anderson, John S. Marken
  • Siglec-12 polypeptides, polynucleotides, and methods of use thereof
    Publication number: 20030040604
    Abstract: Provided herein are polypeptide and polynucleotide sequences for a molecule having homology to the siglec family of polypeptides. Also provided are methods of making and using a siglec-like polypeptide and polynucleotide.
    Type: Application
    Filed: May 29, 2002
    Publication date: February 27, 2003
    Inventors: Dirk M. Anderson, John S. Marken
  • Methods of screening for antagonists and agonists of polypeptides having kinase functions
    Publication number: 20030036051
    Abstract: The invention is directed to purified and isolated human polypeptides having kinase function, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, the use of such polypeptides and fragmented peptides in phosphorylation reactions and as molecular weight markers, the use of such polypeptides and fragmented peptides as controls for peptide fragmentation, the use of such polypeptides in screening assays, and kits comprising these reagents.
    Type: Application
    Filed: December 18, 2001
    Publication date: February 20, 2003
    Applicant: Immunex Corporation
    Inventors: G. Duke Virca, Timothy A. Bird, Dirk M. Anderson, John S. Marken
  • Human cDNAs encoding polypeptides having kinase functions
    Patent number: 6387676
    Abstract: The invention is directed to purified and isolated human polypeptides having kinase function, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, the use of such polypeptides and fragmented peptides in phosphorylation reactions and as molecular weight markers, the use of such polypeptides and fragmented peptides as controls for peptide fragmentation, the use of such polypeptides in screening assays, and kits comprising these reagents.
    Type: Grant
    Filed: June 23, 2000
    Date of Patent: May 14, 2002
    Assignee: Immunex Corporation
    Inventors: G. Duke Virca, Timothy A. Bird, Dirk M. Anderson, John S. Marken